
|Articles|August 28, 2019
The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing
Author(s)Thermo Fisher Scientific
ORC International’s report Implications of Inaccurate Forecasting on Biologics Drug Substance Manufacturing explores causes, consequences, and potential solutions to forecasting challenges related to biopharmaceutical drug substance manufacturing. It provides insight and perspective on key themes that emerge from the report, offering additional solutions to prepare for inevitable forecast inaccuracies.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
FAQ: Key Innovations in Drug Delivery and Formulation in 2025
2
Trends and Challenges Impacting Highly Potent API Development
3
Leap Forward in Automation Anticipated for Small-Molecule Drug Product Manufacturing
4
Raman Spectroscopy—A Game-Changer in the Fight Against Counterfeit Drugs
5
